Janus Henderson Group
FLNA

Janus Henderson Group’s Filana Therapeutics FLNA Stock Holding History

Janus Henderson Group’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,436
Closed -$39K – 2542
2024
Q4 		$39K Hold
16,436
– – ﹤0.01% 2520
2024
Q3 		$484K Hold
16,436
– – ﹤0.01% 2051
2024
Q2 		$202K Sell
16,436
-205
-1% -$4.32K ﹤0.01% 2383
2024
Q1 		$338K Buy
16,641
+1
+0% +$23 ﹤0.01% 2187
2023
Q4 		$374K Sell
16,640
-31
-0.2% -$655 ﹤0.01% 2121
2023
Q3 		$277K Buy
16,671
+9
+0.1% +$178 ﹤0.01% 2229
2023
Q2 		$408K Sell
16,662
-28
-0.2% -$674 ﹤0.01% 2092
2023
Q1 		$402K Buy
16,690
+9,156
+122% +$254K ﹤0.01% 2137
2022
Q4 		$222K Hold
7,534
– – ﹤0.01% 2137
2022
Q3 		$315K Buy
7,534
+1
+0% +$27 ﹤0.01% 2191
2022
Q2 		$212K Buy
7,533
+1
+0% +$25 ﹤0.01% 2275
2022
Q1 		$280K Buy
+7,532
New +$319K ﹤0.01% 2268

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Janus Henderson Group's FLNA Position: Q1 2025 in Review

Janus Henderson Group sold out of Filana Therapeutics (FLNA) in Q1 2025, closing a stake of 16,436 shares — an estimated $39K sold.

Janus Henderson Group first reported a position in FLNA in Q1 2022 and held it in 12 quarters. The position peaked at $484K in Q3 2024. 117 funds tracked by Wall St. Rank hold FLNA as of Q1 2025.

  • Janus Henderson Group reported no remaining Filana Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Janus Henderson Group sold 16,436 Filana Therapeutics shares in Q1 2025, an estimated $39K.
  • Janus Henderson Group first reported a position in Filana Therapeutics in Q1 2022 and held it in 12 quarters.
  • Janus Henderson Group's Filana Therapeutics position peaked at $484K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2025.

Based on Janus Henderson Group's 13F filing for Q1 2025, filed 15 May 2025.